Tagged with EALTH

Switzerland Switzerland may have a world class healthcare system, but small adjustments are needed to ensure incentives for payer and providers are properly aligned with the patient’s ultimate quality and value of care. Dr. Cassis, could you please introduce yourself, with reference to your experience and current responsibilities in the realm…

Luxembourg Novartis’ newest Head for the Grand-Duchy of Luxembourg provides a fascinating insight into the Luxembourg market and reveals how this small nation has found itself in pole position for future pharmaceutical innovation. After over a decade with GSK, you joined Novartis one and half years ago. What made you join…

Slovakia The basics on the country of Slovakia: name, date of independence, geography, population, currency, language, and capital. Slovakia is well integrated into the international community, with membership of the majority of large transnational institutions. Slovakia is located at the heart of Europe, within a short flight of almost every other…

Switzerland With over 50 years of history in Switzerland, Zambon operates in Canton Ticino one of Zambon’s two major global production centers. Swiss Market  Manager Giampiero Roncoroni discusses the unique features of the Swiss market, and how a particular focus on the OTC/OTX market has been a key factor of success…

Singapore Takeda’s President of Emerging Markets Business Unit, Giles Platford, speaks about his assignments across various global markets, his leadership philosophy, as well as the impressive international growth of the company.   I feel a strong sense of responsibility and obligation working for a company that has potentially life-saving and life-transforming…

Singapore Eli Lilly and Company General Manager of South ASEAN, Dr. Faiz Ansari speaks about the expanded scope of his role,  Lilly’s pipeline, and the approach that Lilly has taken to support healthcare delivery and improve patients‘ access to treatment and to support programs in a region that is so inherently…

Singapore In an exclusive interview with Alan Ong, Executive Vice President of Asia Pacific and Global Head of Medical Devices and Diagnostics at INC Research, he highlights the current trends facing CROs in the region and the increasing capabilities and footprint of INC Research in Singapore. As the Executive Vice President…

Singapore In an interview with Takeda’s President of Emerging Markets Business Unit, Giles Platford portrays a vitalized focus on emerging markets and explains why those countries are positioned as one of three key growth drivers for the company. With Takeda’s recently unveiled Access-to-Medicines (AtM) strategy, he also characterizes the role of…

Singapore Cerner’s managing director of Southeast Asia, Rebecca LaNasa highlights the key importance that Singapore—as the company’s third office outside the U.S.—serves in implementing and piloting new forms of health care information technology (HIT), while elaborating on how the company’s comprehensive portfolio of solutions can actually help both developed and developing…

Slovakia Deloitte Slovakia’s Chairman, Vladimir Masar, talks about the transferability of his financial banking experience to the consultancy sector, the country’s attractiveness to foreign investment and the current state of its healthcare system. Given your extensive experience of the public and private sectors, could you tell our global executive readers about…

Switzerland Sintetica, Switzlerland’s longtime leader in local anesthesia and pain relief with development efforts in neuromodulation, started an ambitious internationalization strategy in 2011. CEO Augusto Mitidieri discusses the company’s expansion progress and highlights areas of unmet medical need around anesthetics. What are the most significant unmet medical needs in the realm…

Mexico This chart gives an insight into the phenomenal importance of the pharmaceutical industry to Mexico, in terms of both monetary value and employment created. Public, private, and out of pocket healthcare coverage in Mexico. The growth of the Mexican pharma industry by patented, generic and OTC segments. API Manufacturing compared…